On Monday ProKidney Corp (NASDAQ: PROK) opened lower -6.86% from the last session, before settling in for the closing price of $3.06. Price fluctuations for PROK have ranged from $0.46 to $7.13 over the past 52 weeks.
Company’s average yearly earnings per share was noted 18.45% at the time writing. With a float of $97.78 million, this company’s outstanding shares have now reached $133.42 million.
ProKidney Corp (PROK) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ProKidney Corp is 27.57%, while institutional ownership is 30.14%. The most recent insider transaction that took place on Jul 08 ’25, was worth 312,510. In this transaction Chief Regulatory Officer of this company sold 103,480 shares at a rate of $3.02, taking the stock ownership to the 0 shares. Before that another transaction happened on Jul 08 ’25, when Company’s Officer proposed sale 103,480 for $0.61, making the entire transaction worth $62,761.
ProKidney Corp (PROK) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.14 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.22) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.45% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Check out the current performance indicators for ProKidney Corp (PROK). In the past quarter, the stock posted a quick ratio of 11.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1582.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Compared to the last year’s volume of 4.82 million, its volume of 1.81 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 25.60%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 35.05%, which indicates a significant increase from 18.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.76, while its 200-day Moving Average is $1.79. Nevertheless, the first resistance level for the watch stands at $3.06 in the near term. At $3.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.45. If the price goes on to break the first support level at $2.67, it is likely to go to the next support level at $2.50. Should the price break the second support level, the third support level stands at $2.28.
ProKidney Corp (NASDAQ: PROK) Key Stats
There are currently 294,282K shares outstanding in the company with a market cap of 838.70 million. Presently, the company’s annual sales total 80 K according to its annual income of -61,190 K. Last quarter, the company’s sales amounted to 220 K and its income totaled -16,550 K.
